← Back to Patent Explorer
US4702917A Expired / Lapsed US ⏱️ 0.0 years remaining

Porous bioabsorbable polyesters

Assignee: RTI International
•
Filing: 1985-11-18
•
Granted: 1987-10-27
•
Expires: 2005-11-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polylactones blended with a polyether and then shaped are leached with aqueous solution of an organic solvent such as alcohol or acetone to elute selectively the polyether and form interconnected pores within the shaped polylactone. The result is a shaped article suitable for use a reservoir for the controlled release of high molecular weight drugs.

Inventors

  • 👤 Anton Schindler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:06
CPC Classifications
A; A61; A61J; A61J3/00; A61K; A61K9/00; A61K9/0087; A61K9/0092; A61K9/70; A61K9/7007; Y; Y10; Y10T; Y10T428/00; Y10T428/13

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 100 words
A article suitable for use as a controlled release reservoir for high molecular weight drugs, comprising a porous polymer formed by (a) shaping a polylactone in the presence of a polyether comprised of polyoxypropylene and polyoxyethylene; and (b) selectively eluting said polyether with an aqueous solution of an organic solvent from said shaped polylactone at a temperature of about 40° C. to 55° C. to form interconnected pores therein, the resulting pore volume exceeding the amount of material eluted, the resulting product defining a sealed interior reservoir in communication with said pores, which reservoir is suitable to receive said drugs.
Claim 2
Dependent Claim 100 words
A article suitable for use as a controlled release reservoir for high molecular weight drugs, comprising a porous polymer formed by (a) shaping a polylactone in the presence of a polyether comprised of polyoxypropylene and polyoxyethylene; and (b) selectively eluting said polyether with an aqueous solution of an organic solvent from said shaped polylactone at a temperature of about 40° C. to 55° C. to form interconnected pores therein, the resulting pore volume exceeding the amount of material eluted, the resulting product defining a sealed interior reservoir in communication with said pores, which reservoir is suitable to receive said drugs.
Claim 3
Dependent Claim 13 words
The article of claim 1 wherein said polyether is endcapped with acetyl groups.
Claim 4
Dependent Claim 22 words
The article of claim 1 wherein the endcapped polyether of claim 2 is added to the monomeric lactone prior to the polymerization.
Claim 5
Dependent Claim 28 words
The article of claim 1 wherein, prior to said selective elution step, said polyether is present in an amount of 5-50% based on the weight of said blend.
Claim 6
Dependent Claim 22 words
The article of claim 4 wherein said polyether is present in an amount of 10-30% based on the weight of said blend.
Claim 7
Dependent Claim 10 words
The article of claim 1, wherein said polylactone is polycaprolactone.
Claim 8
Dependent Claim 22 words
The article of claim 1, wherein said polylactone is a copolymer formed from caprolactone and at least one other lactone or bis-lactone.
Claim 9
Dependent Claim 16 words
The article of claim 1, wherein said shaped polylactone is in the form of a tube.
Claim 10
Dependent Claim 17 words
The article of claim 1, wherein said organic solvent is acetone present in an amount of 20-70%.
Claim 11
Dependent Claim 19 words
The article of claim 1, wherein said organic solvent is methanol or ethanol present in an amount of 20-50%.
Claim 12
Independent Claim 86 words
A method of fabricating a porous shaped article suitable for use as a controlled release reservoir for high molecular weight drugs, comprising: (a) shaping a blend of a polylactone and polyether comprised of polyoxypropylene and polyoxyethylene to form a shaped article; and (b) selectively eluting said polyether from said shaped article with an aqueous solution of an organic solvent to form interconnected pores therein, said elution step being conducted under temperature conditions such that the resulting pore volume is greater than the amount of material eluted.
Claim 13
Independent Claim 86 words
A method of fabricating a porous shaped article suitable for use as a controlled release reservoir for high molecular weight drugs, comprising: (a) shaping a blend of a polylactone and polyether comprised of polyoxypropylene and polyoxyethylene to form a shaped article; and (b) selectively eluting said polyether from said shaped article with an aqueous solution of an organic solvent to form interconnected pores therein, said elution step being conducted under temperature conditions such that the resulting pore volume is greater than the amount of material eluted.
Claim 14
Dependent Claim 24 words
The method of claim 11 wherein said polyether is endcapped with acetyl groups and is added to the monomeric lactone prior to the polymerization.
Claim 15
Dependent Claim 28 words
The method of claim 12, wherein prior to said selective elution step, said polyether is present in an amount of 5-50% based on the weight of said blend.
Claim 16
Dependent Claim 22 words
The method of claim 13, wherein said polyether is present in an amount of 10-30% based on the weight of said blend.
Claim 17
Dependent Claim 10 words
The method of claim 12, wherein said polylactone is polycaprolactone.
Claim 18
Dependent Claim 22 words
The method of claim 12, wherein said polylactone is a copolymer formed from caprolactone and at least one other lactone or bis-lactone.
Claim 19
Dependent Claim 16 words
The method of claim 12, wherein said shaped polylactone is in the form of a tube.
Claim 20
Dependent Claim 17 words
The method of claim 12, wherein said organic solvent is acetone present in an amount of 20-70%.
Claim 21
Dependent Claim 19 words
The method of claim 12, wherein said organic solvent is methanol or ethanol present in an amount of 20-50%.

References Cited (Backward Citations)

US3423491A Cited
US3887699A Cited
US4076656A Cited
US4148871A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-10-26 1991-04-27 1991-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-10-26 1995-04-27 1995-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-10-26 1999-04-27 1999-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag